Dirlotapide
From Wikipedia, the free encyclopedia
Dirlotapide is a drug used to treat obesity in dogs. It is manufactured by Pfizer and marketed as Slentrol.
It works as a selective microsomal triglyceride transfer protein inhibitor. This blocks the assembly and release of lipoproteins into the bloodstream, thereby reducing fat absorption. It also elicits a satiety signal from lipid-filled cells lining the intestine.
It is supplied as an oral solution. It is not intended for use in humans or cats.
On January 5 2007, the FDA approved Slentrol, the first time the FDA has approved a drug for obese dogs.[1]
[edit] External Links
[edit] References
- ^ FDA approves 1st drug for obese dogs. Yahoo}. Retrieved on 2007-01-06.
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
